![]() |
All Themes | ![]() |
Business | ![]() |
Education | ![]() |
Entertainment | ![]() |
Health | ![]() |
Law | ![]() |
Politics | ![]() |
Science | ![]() |
Sports | ![]() |
Technology | ![]() |
World | ![]() |
Top Stories | ![]() |
|
Targeted Kidney Cancer Drugs Show Promise
YAHOO
HealthDay - SUNDAY, June 4 (HealthDay News) -- The treatment of kidney cancer, a notoriously difficult disease to overcome, is moving into a new era, oncologists reported Sunday.
|
Drugs hold promise in kidney cancer fight
YAHOO
AP - For decades, it has been one of cancer's great mysteries: Why do about 4 percent of kidney tumors spontaneously disappear?
|
|||||||||||
|
Onyx, Bayer face Pfizer in cancer drug wars
YAHOO
Reuters - A kidney cancer drug made by Bayer AG
and Onyx Pharmaceuticals Inc. showed promise in a small lung
cancer trial, according to data released on Sunday, further
fueling competition with a drug from Pfizer Inc.
|
Wyeth kidney cancer drug shows promise in trial
YAHOO
Reuters - Wyeth said on Sunday that interim
results of a late-stage trial of its experimental kidney cancer
drug significantly increased survival in patients compared to
standard therapy.
|
Data suggest Pfizer drug new kidney cancer standard
YAHOO
Reuters - Pfizer Inc.'s kidney cancer drug
Sutent will soon become the favored first-line treatment for
advanced forms of the disease, based on its ability to prolong
survival in a late-stage trial described on Sunday, researchers
said.
|
|||||||||||
![]() |
Categories | ![]() |
Latest Kidney Cancer News | ![]() |
Related: | ![]() |
|
Health Links Trade links |
Glaxo drug slows breast cancer in study
YAHOO
Reuters - An experimental drug added to
chemotherapy slowed aggressive, late-stage breast cancers that
resumed growing despite standard treatment with the drug
Herceptin, U.S. researchers said on Saturday.
Sources: YAHOO
Glaxo's Tykerb helps some with kidney cancer: study
YAHOO
Reuters - GlaxoSmithKline's experimental pill
Tykerb helped some patients with advanced kidney cancer live
longer, French researchers reported on Saturday.
Sources: YAHOO
Bayer moves closer to EU approval of kidney cancer treatment
YAHOO
AFP - Bayer, the German pharmaceuticals and chemicals giant, said it had moved a step closer to having its new kidney cancer drug Nexavar (sorafenib) approved for marketing in Europe.
Sources: YAHOO
Less Invasive Surgery Shows Promise for Kidney Cancer
YAHOO
American Cancer Society - Summary: A less invasive type of surgery for kidney
cancer offers good results, at least in the short term, researchers
report in the Journal of Urology. A team from the Cleveland Clinic
Foundation says patients fared well when their tumors were removed
laparoscopically -- using a few small incisions instead of opening the
entire abdomen. But the procedure is complicated and requires expert
surgeons, they warn.
Sources: YAHOO
Organ Removal Not the Only Option for Kidney Cancer Patients
YAHOO
HealthDay - THURSDAY, Feb. 9 (HealthDay News) -- A small tumor in a kidney may not always mean surgeons have to remove the whole organ, researchers report.
Sources: YAHOO
Organ Removal Not the Only Option for Kidney Cancer Patients
YAHOO
HealthDay - THURSDAY, Feb. 9 (HealthDay News) -- A small tumor in a kidney may not always mean surgeons have to remove the whole organ, researchers report.
Sources: YAHOO
Moderate drinking may lower kidney cancer risk
YAHOO
Reuters - Moderate alcohol intake appears
to be associated with a decreased risk of kidney cancer in
middle-aged and older women, according to a study conducted in
Sweden.
Sources: YAHOO
FDA Approves Nexavar for Kidney Cancer
YAHOO
American Cancer Society - The US Food and Drug Administration on Tuesday approved the
drug Nexavar (sorafenib tosylate) for the treatment of advanced kidney
cancer.
Sources: YAHOO
|
| Pages: | [1] |